Information Provided By:
Fly News Breaks for January 18, 2017
FWP, BIIB
Jan 18, 2017 | 08:56 EDT
After Biogen (BIIB) reached an IP deal with Forward Pharma (FWP), BMO Capital analyst M. IanSomaiya notes that the deal limits royalty payments to 10% in areas where Forward wins patent litigation. The analyst says that the royalty was lower than the higher amounts projected by Forward and removes an overhang on Biogen. He keeps a Market Perform rating on Biogen.
News For BIIB;FWP From the Last 2 Days
There are no results for your query BIIB;FWP